MarketCapExport financials
Medigus Ltd. (MDGS)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Medigus Ltd. Income Statement 2024-2011 | MDGS
Brief overview of profit and loss at Medigus Ltd.
This overview is based on financial performance over the past five years. Medigus Ltd. reported revenue of 273 thousand dollars in 2019 and 29.9 million dollars by 2024. The five-year change reached +10837%, while CAGR stood at 155.7%. Revenue growth reflects a pronounced phase of business expansion.
Gross profit was −182 thousand dollars at the start and 6.7 million dollars at the end of the period (+3772%). Gross profit as a share of revenue changed from −66.7% to 22.4%. The margin shift points to a more favorable sales-and-cost structure.
The five-year EBITDA result moved by +100%: from −$14.2 million to $0. EBITDA underperformed the top-line trend. Comparing the endpoints gives EBITDA margins of −5193.8% and 0%. The company improved its ability to convert sales into EBITDA.
Conclusion
The financial profile remains mixed, with strengths and risks moving in different directions. Key strengths include sales growth, better sales economics and positive operating leverage. The most visible risks are a narrow EBITDA buffer. Future reports should be judged by revenue momentum, margins, and the conversion of sales into net income.
Annual Income Statement Medigus Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
- | - | - | - | - | 135 M | 103 M | 764 M | 660 M | 2.89 B | - | - | - | - |
Shares |
- | - | - | - | - | 78.1 M | 42 M | 126 M | 34.4 M | 28.4 M | - | - | - | - |
Historical Prices |
2.36 | 2.36 | 4.1 | 1.03 | 2.8 | 1.73 | 2.53 | 5.8 | 18.6 | 102 | - | - | - | - |
Net Income |
- | - | - | 4.05 M | - | -14.2 M | -6.58 M | -2.55 M | -8.98 M | -9.48 M | - | - | - | - |
Revenue |
29.9 M | 91.7 M | 91.9 M | 10.1 M | 531 K | 273 K | 436 K | 467 K | 549 K | 619 K | - | - | - | - |
Gross Profit |
6.68 M | 11.8 M | 14.5 M | 4.8 M | -503 K | -182 K | -171 K | -49 K | 373 K | 344 K | - | - | - | - |
Operating Income |
- | - | - | -9.9 M | -7.38 M | -14.4 M | -6.67 M | -6.11 M | -9.09 M | -9.56 M | - | - | - | - |
EBITDA |
- | - | - | -9.9 M | -7.38 M | -14.2 M | -6.58 M | -2.55 M | -8.98 M | -9.42 M | - | - | - | - |
Operating Expenses |
- | - | - | - | - | 4.02 M | 6.5 M | 6.06 M | 9.46 M | 9.85 M | - | - | - | - |
General and Administrative Expenses |
- | - | - | 9.96 M | - | 2.76 M | 1.98 M | 2.16 M | 1.56 M | 163 K | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Medigus Ltd.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1.15 M | - | - | - | 788 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 54 K | - | - | - | 82 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -72 K | - | - | - | 53 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1.12 M | - | - | - | -1.35 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1.12 M | - | - | - | -1.35 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 337 K | - | - | - | 550 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
The income statement is one of the three key financial reports of a company Medigus Ltd. (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
USA
Britain
Canada
China
France
Israel
